Explore 3 Stock Ideas & Industry Insights Download Free Report

Premium

AFT Pharmaceuticals (NZX:AFT) expects revenue growth to accelerate in H2FY25

AFT Pharmaceuticals Limited (NZX:AFT) is a multinational company specializing in the development, marketing, and distribution of a diverse range of pharmaceutical products. The company is listed on the New Zealand Stock Exchange and the Australian Stock Exchange.

Team Kalkine | 20 December 2024

PaySauce' (NZX:PYS) Recurring Revenue Jumps 20% in H1FY25, Moves Closer Towards Annualised Goal of NZD10Mn

PaySauce Limited (NZX:PYS) is an award-winning FinTech company that provides SaaS payroll solutions tailored for New Zealand-based small and medium-sized businesses.

Team Kalkine | 17 December 2024

Ryman Healthcare (NZX:RYM) expects negative free cash flow in FY25, records 50% drop in NPAT in 1HFY25

Founded in 1984, Ryman Healthcare Limited (NZX:RYM) is a New Zealand-based company that offers retirement living options. The company is listed on the NZX 50 index and has a market cap of NZD 2.92 billion.

Team Kalkine | 12 December 2024

Heartland Group Holdings (NZX:HGH) targets NPAT of NZD 200Mn by FY2028, eyes ROE of 12-14%

Heartland Group Holdings Limited (NZX:HGH) is an NZX-listed financial services company. The company has operations in Australia and New Zealand. The company has a market cap of NZD 899.9 million.

Team Kalkine | 09 December 2024

AFT Pharmaceuticals (NZX: AFT) Forecasts FY25 Operating Profit Between NZD 15-20Mn

AFT Pharmaceuticals Limited (NZX:AFT)is a multinational pharmaceutical company that is engaged in the development, marketing and distribution a broad portfolio of pharmaceutical products. Market capitalisation of AFT is NZD 295.7 million.

Team Kalkine | 06 December 2024